Royce & Associates LP Neuronetics, Inc. Transaction History

Royce & Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.09 - $3.71 $529,815 - $940,485	-253,500 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$2.84 - $4.52 $377,720 - $601,160	-133,000 Reduced 34.41%	253,500 $768,000
Q4 2021 Feb 07, 2022	BUY	$3.87 - $6.59 $193,500 - $329,500	50,000 Added 14.86%	386,500 $1.72 Million
Q3 2021 Nov 10, 2021	SELL	$6.22 - $15.54 $4.17 Million - $10.4 Million	-670,694 Reduced 66.59%	336,500 $2.21 Million
Q2 2021 Aug 06, 2021	SELL	$10.15 - $17.25 $196,910 - $334,650	-19,400 Reduced 1.89%	1,007,194 $16.1 Million

Q1 2021 May 10, 2021	BUY	$10.6 - $21.27 $975,581 - $1.96 Million	92,036 Added 9.85%	1,026,594 $12.7 Million
Q4 2020 Feb 08, 2021	BUY	$4.95 - $11.45 $3.74 Million - $8.64 Million	754,558 Added 419.2%	934,558 $10.4 Million
Q3 2020 Nov 12, 2020	BUY	$1.82 - $5.87 $327,600 - $1.06 Million	180,000 New	180,000 $875,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.